NFKB1 and chronic myelogenous leukemia, BCR-ABL1 positive: The triggering of NF-κB-dependent transcription is enhanced in ALL and chronic myeloid leukemia (CML) due to the production of Bcr-Abl and the improvement in the conversion function of the RelA/p65 monomer of NF-κB [16].